TD Cowen Lowers Acadia Healthcare (NASDAQ:ACHC) Price Target to $22.00

Acadia Healthcare (NASDAQ:ACHC) had its price target decreased by investment analysts at TD Cowen from $25.00 to $22.00 in a report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen’s target price points to a potential upside of 89.04% from the company’s previous close.

ACHC has been the topic of a number of other reports. Bank of America lowered shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $21.50 to $13.00 in a report on Wednesday, December 3rd. Barclays dropped their price target on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Thursday, December 4th. Leerink Partnrs cut Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 3rd. Cantor Fitzgerald set a $17.00 target price on Acadia Healthcare in a research report on Wednesday, December 3rd. Finally, Royal Bank Of Canada cut their price target on shares of Acadia Healthcare from $19.00 to $17.00 and set an “outperform” rating on the stock in a report on Wednesday. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and an average price target of $18.92.

Acadia Healthcare Stock Down 2.3%

Shares of ACHC stock traded down $0.27 during trading hours on Friday, reaching $11.64. 281,197 shares of the company’s stock were exchanged, compared to its average volume of 2,680,162. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $45.61. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.73. The stock has a market cap of $1.07 billion, a PE ratio of 9.97, a PEG ratio of 3.08 and a beta of 0.88. The stock’s fifty day moving average price is $14.93 and its two-hundred day moving average price is $20.05.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.71 by $0.01. The firm had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. During the same period last year, the firm posted $0.91 EPS. Acadia Healthcare’s revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Research analysts predict that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the company. Allworth Financial LP lifted its stake in shares of Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after purchasing an additional 1,177 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares in the last quarter. Hantz Financial Services Inc. raised its position in shares of Acadia Healthcare by 501.9% in the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after acquiring an additional 1,822 shares during the period. CWM LLC boosted its stake in shares of Acadia Healthcare by 105.1% during the 2nd quarter. CWM LLC now owns 2,633 shares of the company’s stock worth $60,000 after acquiring an additional 1,349 shares in the last quarter. Finally, Quent Capital LLC acquired a new stake in shares of Acadia Healthcare during the 3rd quarter valued at about $71,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.